Lamas GA, Bhatnagar A
Lead and cadmium are established cardiovascular toxins with well-documented links to atherosclerosis and cardiac events. This review examines how edetate disodium removes these metals from the body and explores the unexpected cardiovascular benefits observed in the TACT trial. The authors argue that heavy metal removal — not calcium displacement — is the most plausible mechanism behind TACT's positive findings.
Following a single edetate disodium infusion, urinary excretion of lead increased by 3,830% and cadmium by 514% — providing direct evidence that EDTA actively removes the metals most strongly linked to cardiovascular damage.
Bottom line — This review article links two previously separate research streams: TACT's unexpectedly positive cardiovascular results, and the growing epidemiological evidence that heavy metal exposure (particularly lead and cadmium) is itself a cardiovascular risk factor. The authors propose that EDTA's benefit in TACT may stem from heavy metal removal rather than direct calcium chelation, and outline the rationale for TACT2. Read alongside TACT2's later null result (Study 008), the review's core argument — that environmental heavy metals are a modifiable cardiovascular risk factor — has held up better than its specific TACT-replication hypothesis.